NDLI: Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Guo, Xiao-jing Ye, Xiao-fei Wang, Xing-xing Wang, Jing Shi, Wen-tao Gao, Qing-bin Zhang, Tian-yi Xu, Jin-fang Zhu, Tian-tian He, Jia
Spatial Coverage	China
Description	Country affiliation: China Author Affiliation: Guo XJ ( Second Military Medical University, Department of Health Statistics , Shanghai, 200433 , China.)
Abstract	PURPOSE: The goal of this study was to clarify the reporting patterns of self-reported adverse drug reactions (ADRs) in China. METHODS: A variety of sources were searched, including the official website of China FDA, the national center for ADR monitoring center, publications from PubMed, and so on. We retrieved the relevant information and made descriptive and comparative analysis from the year 2009 to 2013. RESULTS: The ADR reporting numbers were 638,996, 692,904, 852,799, 1,200,000 and 1,317,000 from 2009 to 2013, respectively. Healthcare professionals contributed significantly, and their proportion always exceeded 80% before 2012. The average report per million inhabitants has increased from 479 to 983 from 2009 to 2013. However, the proportion of new or serious report was always below 25%. The reports mainly concern anti-infective agents and traditional Chinese medicine (TCM), especially TCM injection. The proportion of ADR reports in geriatric patients has increased for 4 consecutive years. CONCLUSIONS: ADR report numbers and reporting rates in China are on the rise. However, the proportion of new or serious reports as well as the proportion of reports contributed by consumers and pharmaceutical companies are still quite low. More attention should be paid to the elderly, anti-infective agents and TCM, especially TCM injections.
File Format	HTM / HTML
ISSN	14740338
Issue Number	2
Volume Number	14
e-ISSN	1744764X
Journal	Expert Opinion on Drug Safety
Language	English
Publisher	Taylor & Francis
Publisher Date	2015-02-01
Publisher Place	Great Britain (UK)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pharmacology Drug-related Side Effects And Adverse Reactions Epidemiology Periodicals As Topic Trends Age Distribution Anti-infective Agents Adverse Effects China Humans Medicine, Chinese Traditional Self Report Journal Article Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Transforming drug safety information.

Type B adverse drug reactions reported by an immunoallergology department

Vigilance der Tierarzneimittel: Gemeldete unerwünschte Wirkungen im Jahr 2013.

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

Drug-induced crystal nephropathy: an update.

Risks associated with the therapeutic use of fluoroquinolones.

Front-line research of idiosyncratic drug toxicity

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.

Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.

Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.

Similar Documents

Transforming drug safety information.

Type B adverse drug reactions reported by an immunoallergology department

Vigilance der Tierarzneimittel: Gemeldete unerwünschte Wirkungen im Jahr 2013.

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

Drug-induced crystal nephropathy: an update.

Risks associated with the therapeutic use of fluoroquinolones.

Front-line research of idiosyncratic drug toxicity

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.

Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.

Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.